Completed
Efficacy and Safety of YW17 (Laronidase-CinnaGen) Compared to Aldurazyme® in MPS I Patients
NCT06406153
- Conditions
- Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
- Locations
-
- Clinical Research Development Unit of Akbar Hospital, Faculty of Medicine Mashhad, Iran
- Growth and Development Research Center, Childrens Medical Center Tehran, Iran
- Loghman Hospital Tehran, Iran
- Mofid Childrens Hospital Tehran, Iran